Ulcerative Colitis Clinical Research Trials

Birmingham : University of Alabama at Birmingham

An Open-label Study of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease

Birmingham : University of Alabama at Birmingham

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Birmingham : Apex Clinical Trials

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Birmingham :

An Open-label Study of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease

Mobile : Santarus Clinical Investigational Site 1055

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Mobile : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Phoenix : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Little Rock : Arkansas Children's Hospital

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Los Angeles : Gastrointestinal Bioscience

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Los Angeles : Cedars-Sinai Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Montebello : Paramount Medical Specialty

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Sacramento : Capital Gastroenterology Consultants Medical Group

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

San Diego : Desta Digestive Disease Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

San Diego : Clinical Applications Laboratories Inc.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Anaheim : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Anaheim : Santarus Clinical Investigational Site 1043

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Anaheim : Advanced Clinical Research Institute

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Francisco : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Glendale : Research Site Updated

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Glendale : Research Site Updated

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Lakewood : Santarus Clinical Investigational Site 1071

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Los Angeles : Santarus Clinical Investigational Site 1051

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Los Angeles : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Oakland : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Sacramento : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

San Diego : Santarus Clinical Investigational Site 1053

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

San Diego : Santarus Clinical Investigational Site 1003

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

San Diego : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Aurora : University of CO Health Sciences Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Lafayette : Gastroenterology of the Rockies

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Lakewood : Rocky Mountain Gastroenterology Associates P.L.L.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Littleton : Arapahoe Gastroenterology Associates P.C

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Lone Tree : South Denver Gastroenterology

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Pueblo : Lynn Institute of Pueblo

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Wheat Ridge : Western States Clinical Research, Inc.

Ulcerative Colitis Research Study

Denver : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Littleton : Santarus Clinical Investigational Site 1063

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Hamden : Gastroenterology Center of Connecticut, P.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Bridgeport : Research Site Updated

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Hamden : Santarus Clinical Investigational Site 1018

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Hartford : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

New Haven : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Gainesville : University of Florida

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Jacksonville : Borland-Groover Clinic

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Jacksonville : University of Florida, Jacksonville

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Jacksonville : East Coast Institute for Research

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Melbourne : Osler Clinical Research

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Miami : University of Miami Miller School of Medicine

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

New Smyrna Beach : United Medical Research Institute

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Orlando : Internal Medicine Specialists

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Orlando : Compass Research LLC

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Palm Harbor : Advanced Gastroenterology Associates

Ulcerative Colitis

Port Orange : Accord Clinical Research, LLC

Ulcerative Colitis

Tampa : West Wind'r Research & Development, LLC

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Tampa : University of South Florida

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Winter Park : Shafran Gastroenterology Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Boynton : Santarus Clinical Investigational Site 1035

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Gainesville : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Largo : Santarus Clinical Investigational Site 1001

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Maitland : Santarus Clinical Investigational Site 1024

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Miami : Jackson Memorial Hospital

Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease

Miami : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Miami : Research Site Updated

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Miramar : Santarus Clinical Investigational Site 1013

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Naples : Gastroenterology Group of Naples

Dose Escalation and Remission (DEAR)

New Smyrna Beach : Santarus Clinical Investigational Site 1009

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Winter Park : Shafran Gastroenterology Center

Dose Escalation and Remission (DEAR)

Winter Park : Santarus Clinical Investigational Site 1010

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Zephyrhills : Santarus Clinical Investigational Site 1002

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Atlanta : Atlanta Gastroenterology Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Decatur : Atlanta Center for Gastroenterology, P.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Macon : Gastroenterology Associates of Central Georgia

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Newnan : Digestive Research Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Savannah : St. Joseph's/Candler Health System

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Snellville : DLW Research System

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Atlanta : Atlanta Gastroenterology Associates

Dose Escalation and Remission (DEAR)

Atlanta : Santarus Clinical Investigational Site 1054

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Atlanta : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Decatur : Santarus Clinical Investigational Site 1050

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Macon : Pfizer Investigational Site

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Boise : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Chicago : Rush University Medical Center - Treatment Research Center

Dysbiosis in inflammatory bowel disease.

Urbana : Carle Clinic Association P.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Chicago : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Clive : Iowa Digestive Disease Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Clive : Digestive & Liver Consultants

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Clive : Santarus Clinical Investigational Site 1008

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Kansas City : University Of Kansas

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Topeka : Cotton O'Neil Digestive Health Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Pratt : Santarus Clinical Investigational Site 1052

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Topeka : Santarus Clinical Investigational Site 1033

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Lexington : University of Kentucky Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Louisville : University Of Louisville

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Baton Rouge : Gastroenterology Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Metairie : Santarus Clinical Investigational Site 1034

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

New Orleans : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Shreveport : Santarus Clinical Investigational Site 1032

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Portland : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Baltimore : University of Maryland Medical Group

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Chevy Chase : Metropolitan Gastroenterology Group, P.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Chevy Chase : Metropolitan Gastroenterology Group, PC Chevy Chase Clinical Research

Ulcerative Colitis and Crohn’s Disease (IBD) Research Study

Prince Frederick : Shah Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Annapolis : Santarus Clinical Investigational Site 1044

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Baltimore : University of Maryland Medical Center

Dose Escalation and Remission (DEAR)

Chevy Chase : Chevy Chase Clinical Research

Dose Escalation and Remission (DEAR)

Chevy Chase : Santarus Clinical Investigational Site 1057

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Hollywood : Santarus Clinical Investigational Site 1012

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Prince Frederick : Santarus Clinical Investigational Site 1011

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Boston : Boston Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Boston : Massachusetts General Hospital

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Boston : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Worcester : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Dearborn : The Center for Clinical Studies

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Troy : Center for Digestive Health

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Wyoming : Gastroenterology Associates of Western Michigan, P.L.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Chesterfield : Santarus Clinical Investigational Site 1016

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Detroit : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Wyoming : Santarus Clinical Investigational Site 1015

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Plymouth : Minnesota Gastroenterology, P.A.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Rochester : Mayo Clinic

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Minneapolis : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Plymouth : Minnesota Gastroenterology, P.A.

Dose Escalation and Remission (DEAR)

Rochester : Mayo Clinic

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Rochester : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Saint Paul : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Pascagoula : Santarus Clinical Investigational Site 1023

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Kansas City : Truman Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Lee's Summit : Midwest Center for Clinical Research

A rectal suppository study for the treatment of active Ulcerative Proctitis.

Lee's Summit : Midwest Center for Clinical Research

Study of an investigational medication from Bristol-Myers Squibb (BMS-936557) in patients with Active Ulcerative Colitis

Mexico : Center for Digestive and Liver Diseases, Inc.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

St. Louis : Washington University

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

St. Louis : St. Louis Center for Clinical Research

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Jefferson City : Santarus Clinical Investigational Site 1030

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Boys Town : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Las Vegas : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Lebanon : Dartmouth-Hitchcock Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Morristown : Affiliates in Gastroenterology PA

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

New Brunswick : University of Medicine and Dentistry of New Jersey-NJMS

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Vineland : The Gastroenterology Group of South Jersey

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Marlton : South Jersey Gastroenterology

Dose Escalation and Remission (DEAR)

Marlton : Santarus Clinical Investigational Site 1056

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Mays Landing : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Morristown : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Vineland : Santarus Clinical Investigational Site 1022

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Bayside : Hepatobiliary Associates of New York

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Cheektowaga : Digestive Health Physician

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Great Neck : Long Island Clinical Research Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Merrick : Long Island Gastroenterology Group, P.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

New York : The Rockefeller University Hospital

Inflammatory Bowel Disease Exacerbation and Changes in Gut Microbiome and Innate Immunity

New York : Present Chapman Marion Steinlauf MD PC

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

New York : New York Presbyterian Hospital

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Pittsford : Kim, Chung MD (Private Practice)

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Poughkeepsie : Gastroenterology Associates

Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients with Active Ulcerative Colitis.

Rochester : University of Rochester

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Setauket : Long Island Digestive Disease Consultants

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Stonybrook : SUNY Stony Brook University Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Syracuse : Syracuse Gastroenterological Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Brooklyn : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Buffalo : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Great Neck :

Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Great Neck : Santarus Clinical Investigational Site 1072

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Great Neck : Santarus Clinical Investigational Site 1027

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Lake Success : Santarus Clinical Investigational Site 1067

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Mineola : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

New Hyde Park : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

New York : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Stony Brook : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Chapel Hill : University of North Carolina at Chapel Hill

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Charlotte : Charlotte Gastroentology and Hepatology, P.L.L.C

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Elkin : Northwest Piedmont Clinical Research, Inc.

An Open-label Study of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease

Elkin : Northwest Piedmont Clinical Research, Inc.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Morganton : Burke Research Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Raleigh : Multi-Specialty Research Associates of NC

Do you have ulcerative colitis in remission?

Raleigh : Wake Research Associates

Struggling with Ulcerative Colitis?

Raleigh : Wake Research Associates

Study of Mild to Moderate Ulcerative Colitis

Chapel Hill : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Durham : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Elkin :

An Open-label Study of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease

Wilmington : Santarus Clinical Investigational Site 1073

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Cincinnati : Consultants for Clinical Research Inc.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Dayton : Dayton Science Institute

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Mentor : Santarus Clinical Investigational Site 1017

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Tulsa : Options Health Research

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Oklahoma City : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Portland : The Oregon Clinic-West Hills Gastroenterology

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Pittsburgh : University of Pittsburgh Medical Center - Cancer Centers

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Danville : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Duncansville : Research Site Updated

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Duncansville : Research Site Updated

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Lancaster : Santarus Clinical Investigational Site 1064

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Philadelphia : University of Pennsylvania - Presbyterian Medical Center

Dose Escalation and Remission (DEAR)

Philadelphia : University of Pennsylvania

Study of Cimzia for the Treatment of Ulcerative Colitis

Philadelphia : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Sayre : Santarus Clinical Investigational Site 1066

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Charleston : Medical University Of SC CAR

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Greenville : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Germantown : Gastroenterology Center of the MidSouth, PC

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Nashville : Vanderbilt University Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Knoxville : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Memphis : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Nashville : Inflammatory Bowel Disease Clinic c/o Divison of Gastroenterology, Hepatology and Nutrition, Department of Medicine, School of Medicine, Vanderbilt University

Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use

Austin : Austin Gastroenterology, PA

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Houston : Gastroenterology Consultants

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Houston : Jacon Medical Research Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Houston : Baylor College Of Medicine

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Houston : Bayou City Research, Ltd.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Pasadena : Digestive Health Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

San Antonio : Stone Oak Research Foundation

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

San Antonio : Alamo Medical Research

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Tyler : Digestive Health Specialists of Tyler

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Austin : Santarus Clinical Investigational Site 1059

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Dallas : Dallas VA Medical Center

Exacerbating Factors in Inflammatory Bowel Disease

Dallas : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Fort Worth : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Houston : Santarus Clinical Investigational Site 1019

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Pasadena : Santarus Clinical Investigational Site 1005

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

San Antonio : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

San Antonio : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

The Woodlands : Santarus Clinical Investigational Site 1048

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Sandy : Granite Peaks Gastroenterology

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Lancaster : Santarus Clinical Investigational Site 1014

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Ogden : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Ogden : Santarus Clinical Investigational Site 1020

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Burlington : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Charlottesville : University of Virginia Health System

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Chesapeake : Gastroenterology Associates of Tidewater

A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of XXXXXXXXX Induction Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis.

Fairfax : Gastroenterology Associates of Northern Virginia

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Norfolk : Digestive and Liver Disease Specialist Ltd

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Richmond : Hunter Holmes McGuire VA Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Charlottesville : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Chesapeake : Santarus Clinical Investigational Site 1038

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Fairfax : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Norfolk : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Richmond : Santarus Clinical Investigational Site 1007

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Edmonds : Puget Sound Medical Research

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Seattle : University of Washington

Study of Cimzia for the Treatment of Ulcerative Colitis

Seattle : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Madison : Pharmaseek, LLC

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Milwaukee : Wisconsin Center for Advanced Research

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Milwaukee : Medical College Of Wisconsin

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Madison : Santarus Clinical Investigational Site 1036

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Madison : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Milwaukee : Updated

Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease

Adelaide :

An Open-label Study of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease

Adelaide : Research Site Updated

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Adelaide : Research Site Updated

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Herston : Research Site Updated

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Herston : Research Site Updated

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Nedlands : Research Site Updated

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Prahran : Research Site Updated

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Prahran : Research Site Updated

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Leuven :

An Open-label Study of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease

Leuven :

Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Edmonton :

An Open-label Study of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease

Saskatoon :

An Open-label Study of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease

Beijing : Updated

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Guangzhou : Updated

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Hefei : Updated

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Wuhan : Updated

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Xian : Updated

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Břeclav : Hospital Břeclav

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Brno : Hospital Milosrdných bratří

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Brno : Gastroenterologická ambulance

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Brno : FN sv.Anna

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Cheb : Nemocnice Cheb

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Hodonín : Gastroenterologická ambulance Hodonín

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Hodonín : Hospital TGM Hodonín

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Hradec Králové : FN, II. Interní klinika

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Jičín : Oblastní nemoncice Jičín

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Karlovy Vary : Nemocnice Karlovy Vary

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Karviná : Nemocnice s poliklinikou Ráj

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Litoměřice : Gastroenterologická ambulance Jezuitská

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Litoměřice : Gastroenterologická ambulance Litoměřice

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Ostrava : GASTRO MED, s.r.o.

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Pardubice : Gastromedic s.r.o.

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Plzeň : 4. poliklinika Plzeň, Gastroenterologická ambulance

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Praha :

An Open-label Study of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease

Praha : Ústřední vojenská nemocnice

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Praha 1 : Poliklinika - gastroenterologie

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Praha 2 : Fakultní poliklinika VFN

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Praha 3 : Sanatorium sv. Anny

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Praha 5 : FN Motol

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Praha 9 : Poliklinika Clinicum - Interna

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Přerov : Poliklinika Mens

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Prostějov : Hospital Prostějov

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Rychnov nad Kněžnou : Poliklinika - gastroenterologie Rychnov nad Kněžnou

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Vítkovice : Vítkovická nemocnice

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Zlín : Krajská nemocnice T.Bati

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Allerod : Noreba

Trial on Profermin and Fresubin in Ulcerative Colitis

Aix en Provence Cedex 1 : Centre Hospitalier pays d aix Updated